Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-03-30
2008-12-30
Anderson, Rebecca L (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S331000
Reexamination Certificate
active
07470701
ABSTRACT:
The present invention relates to new substituted five-membered compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds. The compounds of the invention have the following general formula:
REFERENCES:
patent: 3908012 (1975-09-01), De Angelis et al.
patent: 6034093 (2000-03-01), Ewing et al.
patent: 6897220 (2005-05-01), Delorme et al.
patent: WO 00/75129 (2000-12-01), None
patent: WO 01/62233 (2001-08-01), None
patent: WO 02/083667 (2002-10-01), None
patent: WO 03/004472 (2003-01-01), None
patent: WO 03/008405 (2003-01-01), None
patent: WO 03/037886 (2003-05-01), None
patent: WO 03/086279 (2003-10-01), None
patent: WO 2004/013130 (2004-02-01), None
patent: WO 2004/041813 (2004-05-01), None
patent: WO 2004076412 (2004-09-01), None
patent: WO 2004/089913 (2004-10-01), None
patent: WO 2005066139 (2005-07-01), None
patent: WO 2005074642 (2005-08-01), None
CAS Abstracts provided.
Fisera et al., “Furan Derivatives LXXIX. Synthesis andMas Spectra of Some Pydridylfuran Derivatives . . . ” Data Accession No. 1977 171213 Abstract (Chemical Abstracts Service).
Zhao et al., “Arotinololis a Weak Partial Agonist on beta 3-Adrenergic Receptors in Brown Adipocytes” Data Accession No. 2001:547115 andCanadian J. of Physiology and Pharmacology 79(7) :585-593.
Jefferson Ann B.
Lin Xiaodong
Rico Alice
Walter Annette
Wang Xiaojing Michael
Anderson Rebecca L
Harbin Alisa A.
Kathardekar Vinit
Nolan Jason M
Novartis Vaccines and Diagnostics Inc.
LandOfFree
Substituted 2,5-heterocyclic derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 2,5-heterocyclic derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 2,5-heterocyclic derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4032901